POLYCYCLIC GUANINE DERIVATIVES
    3.
    发明授权
    POLYCYCLIC GUANINE DERIVATIVES 失效
    多环芳烃GUANINDERIVATE

    公开(公告)号:EP0538332B1

    公开(公告)日:1997-07-23

    申请号:EP91912779.5

    申请日:1991-06-20

    IPC分类号: C07D487/14

    CPC分类号: C07D487/14

    摘要: Novel polycyclic guanine derivatives of formula (I) and (I'), wherein J is oxygen or sulfur, R1 is hydrogen, alkyl or alkyl substituted with aryl or hydroxy; R2 is hydrogen, aryl, heteroaryl, cycloalkyl, alkyl or alkyl substituted with aryl, heteroaryl, hydroxy, alkoxy, amino, monoalkylamino or dialkylamino, or -(CH¿2?)mTCOR?20¿ wherein m is an integer from 1 to 6, T is oxygen or -NH- and R20 is hydrogen, aryl, heteroaryl, alkyl or alkyl substituted with aryl or heteroaryl; R3 is hydrogen, halo, trifluoromethyl, alkoxy, alkylthio, alkyl, cycloalkyl, aryl, aminosulfonyl, amino, monoalkylamino, dialkylamino, hydroxyalkylamino, aminoalkylamino, carboxy, alkoxycarbonyl or aminocarbonyl or alkyl substituted with aryl, hydroxy, alkoxy, amino, monoalkylamino or dialkylamino; R?a, Rb, Rc and Rd¿ independently represent hydrogen, alkyl, cycloalkyl or aryl; or (R?a and Rb) or (Rc and Rd) or (Rb and Rc¿) can complete a saturated ring of 5- to 7- carbon atoms, or (R?a and Rb¿) taken together and (R?b and Rc¿) taken together, each complete a saturated ring of 5- to 7- carbon atoms, wherein each ring optionally can contain a sulfur or oxygen atom and whose carbon atoms may be optionally substituted with one or more of the following: alkenyl, alkynyl, hydroxy, carboxy, alkoxycarbonyl, alkyl or alkyl substituted with hydroxy, carboxy or alkoxycarbonyl; or such saturated ring can have two adjacent carbon atoms which are shared with an adjoining aryl ring; and n is zero or one. The compounds of formulas (I) and (I') are useful as antihypertensive, muscle relaxant and bronchodilating agents.

    PHOSPHINIC ACID DERIVATIVES
    8.
    发明公开
    PHOSPHINIC ACID DERIVATIVES 失效
    膦衍生物

    公开(公告)号:EP0767794A1

    公开(公告)日:1997-04-16

    申请号:EP95924573.0

    申请日:1995-06-19

    摘要: Phosphinic acid derivatives of structural formula (I) or a pharmaceutically acceptable salt thereof, wherein R is H, alkyl or alkanoyloxymethylene; R1, R2, R3 and R4 are H, alkyl, alkenyl, alkenylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, hydroxyalkyl, carboxyalkyl, thioalkyl, alkoxythioalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl-substituted alkyl or heterocycloalkyl; or R1 and R2 form a cycloalkyl ring of 3-8 members and R3 and R4 are as defined; or R3 and R4 form a cycloalkyl ring of 3-7 members and R1 and R2 are as defined; or R1 and R2 together, and R3 and R4 together, each form a cycloalkyl ring; R5 is -OR9 or -NHR9, wherein R9 is hydrogen or alkyl; n is 0 or 1; A1 is p-aminobenzoyl or p-aminobenzenesulfonyl, or A1 and R5 together form a radical of an α-aminoacyl derivative; and R6 is phenylmethoxycarbonyl, arylcarbonyl, heteroarylcarbonyl or -A2-R7, wherein A2 is a divalent α-iminoacyl radical, and R7 is a substituent on the α-imino atom selected from H, R8OCO-, R8SO2- and R8NHCO-, wherein R8 is aryl, arylmethyl or (C1-C8)alkyl; are disclosed for use as endothelin converting enzyme inhibitors; also disclosed are a genus of novel compounds wherein R?3 and R4¿ form a cycloalkyl ring, and pharmaceutical compositions comprising said novel compounds.

    MUSCARINIC ANTAGONISTS
    10.
    发明授权
    MUSCARINIC ANTAGONISTS 有权
    毒蕈碱受体拮抗剂

    公开(公告)号:EP1343760B1

    公开(公告)日:2009-08-12

    申请号:EP01985584.0

    申请日:2001-12-17

    摘要: Amide derivatives of 1,4 di-substituted piperidine compounds of the formula (I) or a pharmaceutically acceptable salt, ester or solvate thereof, wherein R1 is optionally substituted cycloalkyl, cycloalkylalkyl, aryl, arylalkyl or heteroaryl; R2 is H, alkyl, or optionally substituted cycloalkyl, cycloalkylalkyl, heterocycloalkyl, bridged cycloalkyl, or bridged heterocycloalkyl; R3 is alkyl or -CH¿2?OH; and R4 is H or alkyl; are muscarinic antagonists useful for treating cognitive disorders such as Alzheimer's disease. Pharmaceutical compositions and methods of preparation are also disclosed.